Virologic improvement in patients receiving once-daily saquinavir/mini-dose ritonavir (SQV/r)Therapy in clinical practice

被引：0
|
作者：
Wright, DP [1 ]
Pithey, C [1 ]
机构：
[1] Cent Texas Clin Res, Austin, TX USA
来源：
CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
328
引用
收藏
页码：269 / 269
页数：1
相关论文
共 50 条
  • [1] Positive pharmacoeconomic impact of switching to antiretroviral regimens including once-daily saquinavir/mini-dose ritonavir
    Barry, MG
    Ryan, MB
    Merry, CA
    De Caprariis, PJ
    Israel, DS
    Wright, D
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1205 - 1205
  • [2] Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients
    Autar, RS
    Boffito, M
    Hassink, E
    Wit, FWNM
    Ananworanich, J
    Siangphoe, U
    Pozniak, A
    Cooper, DA
    Phanuphak, P
    Lange, JMA
    Ruxrungtham, K
    Burger, DM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (05) : 908 - 913
  • [3] Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir
    Ananworanich, Jintanat
    Gayet-Ageron, Angele
    Ruxrungtham, Kiat
    Chetchotisakd, Ploenchan
    Prasithsirikul, Wisit
    Kiertiburanakul, Sasisopin
    Munsakul, Warangkana
    Rakasakulkarn, Phitsanu
    Tansuphasawadikul, Somboon
    LeBraz, Michelle
    Jupimai, Thidarat
    Ubolyam, Sasiwimol
    Schutz, Malte
    Hirschel, Bernard
    ANTIVIRAL THERAPY, 2008, 13 (03) : 375 - 380
  • [4] Saquinavir plasma and intracellular concentrations in a once daily dosing combination SQV-SGC- low dose ritonavir in a prospective study in HIV-infected patients
    Lamotte, C.
    Peytavin, G.
    Landman, R.
    Mentre, F.
    Gerbe, J.
    Dohin, E.
    Yeni, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 67 - 67
  • [5] Simplified Protease Inhibitor Trial (SPRINT): Metabolic effects of once daily saquinavir SGC plus ritonavir (SQV/r) vs twice-daily indinavir plus ritonavir (IDV/r)
    Harris, M
    Press, N
    Thorne, A
    Zala, C
    Cahn, P
    Ochoa, C
    Schneider, S
    Hanna, B
    Singer, J
    Montaner, J
    ANTIVIRAL THERAPY, 2004, 9 (06) : L58 - L58
  • [6] 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures
    Johnson, M
    Grinsztejn, B
    Rodriguez, C
    Coco, J
    DeJesus, E
    Lazzarin, A
    Lichtenstein, K
    Wirtz, V
    Righmire, A
    Odeshoo, L
    McLaren, C
    AIDS, 2006, 20 (05) : 711 - 718
  • [7] Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HV-infected patients with standard tuberculosis therapy (TBQD study)
    Ribera, E
    Azuaje, C
    Lopez, RM
    Domingo, P
    Soriano, A
    Pou, L
    Sánchez, P
    Mallolas, J
    Sambea, MA
    Falco, V
    Ocaña, I
    Lopez-Colomes, JL
    Gatell, JM
    Pahissa, A
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (03) : 317 - 323
  • [8] Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis
    Ribera, Esteban
    Azuaje, Carlos
    Lopez, Rosa M.
    Domingo, Pere
    Curran, Adria
    Feijoo, Maria
    Pou, Leonor
    Sanchez, Paquita
    Sambeat, Maria Antonia
    Colomer, Joan
    Lopez-Colomes, Josep Lluis
    Crespo, Manuel
    Falco, Vicenc
    Ocana, Imma
    Pahissa, Albert
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) : 690 - 697
  • [9] The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy
    Cardiello, P
    Srasuebkul, P
    Hassink, E
    Mahanontharit, A
    Samor, T
    Ruxrungtham, K
    Lange, J
    Cooper, D
    Phanuphak, P
    HIV MEDICINE, 2005, 6 (02) : 122 - 128
  • [10] Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study
    van Heeswijk, RPG
    Veldkamp, AI
    Mulder, JW
    Meenhorst, PL
    Lange, JMA
    Beijnen, JH
    Hoetelmans, RMW
    AIDS, 2000, 14 (09) : F103 - F110
12345